Waters Parkerson & Co., LLC Abbott Laboratories Transaction History

Waters Parkerson & Co., LLC

$1.82 Billion
Q4 2024

A detailed history of Waters Parkerson & Co., LLC transactions in Abbott Laboratories stock. As of the latest transaction made, Waters Parkerson & Co., LLC holds 464,309 shares of ABT stock, worth $61.6 Million. This represents 2.89% of its overall portfolio holdings.

Number of Shares

464,309

Previous 466,414 0.45%

Holding current value

$61.6 Million

Previous $53.2 Million 1.24%

% of portfolio

2.89%

Previous 2.7%

31 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2024 Feb 14, 2025	SELL	$111.93 - $119.39 $235,612 - $251,315	-2,105 Reduced 0.45%	464,309 $52.5 Million
Q3 2024 Nov 12, 2024	SELL	$100.07 - $118.13 $252,576 - $298,160	-2,524 Reduced 0.54%	466,414 $53.2 Million
Q2 2024 Aug 12, 2024	BUY	$100.73 - $112.44 $222,109 - $247,930	2,205 Added 0.47%	468,938 $48.7 Million
Q1 2024 May 14, 2024	SELL	$109.52 - $120.96 $696,656 - $769,426	-6,361 Reduced 1.34%	466,733 $53 Million
Q4 2023 Feb 14, 2024	SELL	$90.19 - $110.4 $587,407 - $719,035	-6,513 Reduced 1.36%	473,094 $52.1 Million
Q3 2023 Nov 09, 2023	BUY	$95.53 - $114.62 $176,730 - $212,047	1,850 Added 0.39%	479,607 $46.5 Million
Q2 2023 Aug 14, 2023	BUY	$100.78 - $112.29 $257,593 - $287,013	2,556 Added 0.54%	477,757 $52.1 Million
Q1 2023 May 02, 2023	BUY	$96.86 - $114.01 $83,396 - $98,162	861 Added 0.18%	475,201 $48.1 Million
Q4 2022 Feb 09, 2023	SELL	$95.06 - $111.52 $141,449 - $165,941	-1,488 Reduced 0.31%	474,340 $52.1 Million
Q3 2022 Nov 04, 2022	SELL	$96.76 - $112.03 $40,929 - $47,388	-423 Reduced 0.09%	475,828 $46 Million
Q2 2022 Aug 01, 2022	BUY	$102.07 - $123.37 $278,549 - $336,676	2,729 Added 0.58%	476,251 $51.7 Million
Q1 2022 May 13, 2022	BUY	$114.02 - $139.04 $612,059 - $746,366	5,368 Added 1.15%	473,522 $56 Million
Q4 2021 Feb 14, 2022	SELL	$115.53 - $141.46 $931,171 - $1.14 Million	-8,060 Reduced 1.69%	468,154 $65.9 Million
Q3 2021 Nov 04, 2021	SELL	$116.66 - $129.06 $319,181 - $353,108	-2,736 Reduced 0.57%	476,214 $56.3 Million
Q2 2021 Aug 10, 2021	BUY	$105.79 - $124.53 $421,784 - $496,501	3,987 Added 0.84%	478,950 $55.5 Million
Q1 2021 May 12, 2021	BUY	$108.84 - $128.23 $126,036 - $148,490	1,158 Added 0.24%	474,963 $56.9 Million
Q4 2020 Feb 10, 2021	SELL	$105.0 - $114.42 $278,250 - $303,213	-2,650 Reduced 0.56%	473,805 $51.9 Million
Q3 2020 Nov 16, 2020	SELL	$91.64 - $111.29 $718,091 - $872,068	-7,836 Reduced 1.62%	476,455 $51.9 Million
Q2 2020 Aug 13, 2020	SELL	$76.57 - $98.0 $390,353 - $499,604	-5,098 Reduced 1.04%	484,291 $44.3 Million
Q1 2020 May 11, 2020	BUY	$62.82 - $91.86 $357,634 - $522,958	5,693 Added 1.18%	489,389 $38.6 Million
Q4 2019 Feb 13, 2020	SELL	$78.51 - $87.4 $80,708 - $89,847	-1,028 Reduced 0.21%	483,696 $42 Million
Q3 2019 Nov 13, 2019	SELL	$81.84 - $88.74 $1.05 Million - $1.14 Million	-12,801 Reduced 2.57%	484,724 $40.6 Million
Q2 2019 Aug 06, 2019	SELL	$72.88 - $85.0 $657,523 - $766,870	-9,022 Reduced 1.78%	497,525 $41.8 Million
Q1 2019 May 13, 2019	SELL	$66.22 - $80.06 $405,862 - $490,687	-6,129 Reduced 1.2%	506,547 $40.5 Million
Q4 2018 Feb 12, 2019	SELL	$65.56 - $74.27 $453,871 - $514,171	-6,923 Reduced 1.33%	512,676 $37.1 Million
Q3 2018 Nov 13, 2018	SELL	$60.81 - $73.36 $160,660 - $193,817	-2,642 Reduced 0.51%	519,599 $38.1 Million
Q2 2018 Aug 13, 2018	SELL	$57.57 - $63.54 $69,717 - $76,946	-1,211 Reduced 0.23%	522,241 $31.9 Million
Q1 2018 May 09, 2018	BUY	$56.27 - $63.62 $107,025 - $121,005	1,902 Added 0.36%	523,452 $31.4 Million
Q4 2017 Feb 09, 2018	SELL	$53.68 - $57.47 $287,563 - $307,866	-5,357 Reduced 1.02%	521,550 $29.8 Million
Q3 2017 Nov 13, 2017	BUY	$48.06 - $53.64 $127,743 - $142,575	2,658 Added 0.51%	526,907 $28.1 Million
Q2 2017 Aug 11, 2017	BUY	N/A	524,249	524,249 $25.5 Million

Others Institutions Holding ABT

# of Institutions

3,373

Shares Held

1.36B

Call Options Held

10.6M

Put Options Held

8.73M

View Full List

About ABBOTT LABORATORIES

Ticker ABT
Exchange NYSE
Sector Healthcare
Industry Medical Devices
Shares Outstandng 1,751,219,968
Market Cap $232B
Description
Abbott Laboratories, together with its subsidiaries, discovers, develops, manufactures, and sells health care products worldwide. It operates in four segments: Established Pharmaceutical Products, Diagnostic Products, Nutritional Products, and Medical Devices. The Established Pharmaceutical Products segment provides generic pharmaceuticals for t...

More about ABT

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Waters Parkerson & Co., LLC, based on Form 13F filings with the SEC.

News

Stay updated on Waters Parkerson & Co., LLC with notifications on news.

Account

Waters Parkerson & Co., LLC Abbott Laboratories Transaction History